PROTEOLOGICS - Tel Aviv Stock Exchang
PROTEOLOGICS - Tel Aviv Stock Exchang operates in Real Estate Development.
PROTEOLOGICS - Tel Aviv Stock Exchang (PRTL) - Total Liabilities
Latest total liabilities as of June 2018: ILA5.34 Million ILA
Based on the latest financial reports, PROTEOLOGICS - Tel Aviv Stock Exchang (PRTL) has total liabilities worth ILA5.34 Million ILA as of June 2018.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PROTEOLOGICS - Tel Aviv Stock Exchang - Total Liabilities Trend (2009–2017)
This chart illustrates how PROTEOLOGICS - Tel Aviv Stock Exchang's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PROTEOLOGICS - Tel Aviv Stock Exchang Competitors by Total Liabilities
The table below lists competitors of PROTEOLOGICS - Tel Aviv Stock Exchang ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Indus Gas Limited
LSE:INDI
|
UK | GBX1.06 Billion |
|
Sidney Resources Corp
PINK:SDRC
|
USA | $1.70 Million |
|
Traction Uranium Corp.
OTCQB:TRCTD
|
USA | $69.89K |
|
American Noble Gas Inc.
OTCQB:AMNI
|
USA | $5.95 Million |
Liability Composition Analysis (2009–2017)
This chart breaks down PROTEOLOGICS - Tel Aviv Stock Exchang's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PROTEOLOGICS - Tel Aviv Stock Exchang's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PROTEOLOGICS - Tel Aviv Stock Exchang (2009–2017)
The table below shows the annual total liabilities of PROTEOLOGICS - Tel Aviv Stock Exchang from 2009 to 2017.
| Year | Total Liabilities | Change |
|---|---|---|
| 2017-12-31 | ILA4.80 Million | +188.80% |
| 2016-12-31 | ILA1.66 Million | -2.64% |
| 2015-12-31 | ILA1.71 Million | +97.45% |
| 2014-12-31 | ILA864.00K | -29.24% |
| 2013-12-31 | ILA1.22 Million | -74.65% |
| 2012-12-31 | ILA4.82 Million | -61.49% |
| 2011-12-31 | ILA12.51 Million | -30.73% |
| 2010-12-31 | ILA18.06 Million | -56.45% |
| 2009-12-31 | ILA41.46 Million | -- |